CPHI logo

China Pharma Holdings (CPHI) Company Overview

Profile

Full Name:

China Pharma Holdings, Inc.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

China

IPO:

April 17, 2002

Indexes:

Not included

Website:

http://www.chinapharmaholdings.com

Description:

China Pharma Holdings (CPHI) is a pharmaceutical company that develops, manufactures, and sells a range of generic and specialty drugs. It focuses on innovative treatments for various health conditions, aiming to improve healthcare in China and beyond through quality products and advanced technology.

Key Details

Price

$0.20

Market Cap

$3.89 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$7.01 M(-13.48% YoY)

Annual EPS

-$0.91(+75.93% YoY)

PE Ratio

-

Annual ROE

-52.43%

Annual Debt To Equity

0.61

Beta

0.69

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 26, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 6, 2024

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with CPHI included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
Chinese stocks
Healthcare sector
All stocks
Small cap stocks
Specialty & Generic Drug Manufacturers industry
Best performing stocks last 3 months
Stocks below SMA 200

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.20
CPHI price is $0.20

Price All-time High

$2049.58
CPHI price is currently -99.99% below its historical high of $2049.58

Price Analysts Target

-
CPHI price consensus analysts' forecast is unknown

Price Today Change

-2.42%
CPHI price is down -2.42% today

Price YTD Change

-14.55%
CPHI price is down -14.55% since January 1st

Price 3-Year Change

-99.01%
CPHI price is down -99.01% over the past 3 years

Market cap

Market Cap

$3.89 M
CPHI market capitalization is $3.89 million

Market Cap 3-Year Change

-79.96%
CPHI market capitalization is down -79.96% over the past 3 years

Market Cap All-time High

$174.32 M
CPHI market capitalization is currently -97.77% below its historical high of $174.32 million

Market Cap Sector Rank

11.19%
CPHI market capitalization is higher than 11.19% of companies in Healthcare sector

Technical

Beta

0.69
CPHI beta is 0.69

200-day SMA

$0.23
CPHI price is currently -11.36% below its 200-day simple moving average

14-day RSI

46.26
CPHI 14-day relative strength index is 46.26

30-day Relative Volume

0.21
CPHI 30-day relative volume is 0.21

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$7.01 M
CPHI annual revenue is $7.01 million

Annual Revenue Analysts Estimate

-
CPHI annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-13.48%
CPHI annual revenue is down -13.48% year-on-year

Annual Revenue Sector Rank

27.44%
CPHI annual revenue is higher than 27.44% of companies in Healthcare sector

Profit

Annual Gross Profit

-$281.10 K
CPHI annual gross profit is -$281.10 thousand

Annual Gross Margin

-4.01%
CPHI annual gross profit margin is -4.01%

Annual Operating Profit

-$2.77 M
CPHI annual operating income is -$2.77 million

Annual Operating Margin

-39.47%
CPHI annual operating profit margin is -39.47%

Annual Net Income

-$3.08 M
CPHI annual net profit is -$3.08 million

Annual Net Margin

-43.91%
CPHI annual net profit margin is -43.91%

EPS

Annual EPS

-$0.91
CPHI annual earnings per share is -$0.91

Annual EPS Analysts Estimate

-
CPHI annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+75.93%
CPHI annual earnings per share is up +75.93% year-on-year

Annual EPS Sector Rank

60.79%
CPHI annual earnings per share is higher than 60.79% of companies in Healthcare sector

ROA & ROE

Annual ROA

-17.98%
CPHI annual return on assets is -17.98%

Annual ROE

-52.43%
CPHI annual return on equity is -52.43%

EBIT & EBITDA

Annual EBIT

-$2.75 M
CPHI annual earnings before interest & taxes is -$2.75 million

Annual EBITDA

$8400.00
CPHI annual EBITDA is $8400.00

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CPHI price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CPHI price to earnings ratio is unknown

PB Ratio

PB Ratio

0.60
CPHI price to book ratio is 0.60

PB Ratio Sector Rank

32.26%
CPHI price to book ratio is higher than 32.26% of companies in Healthcare sector

PS Ratio

PS Ratio

0.70
CPHI price to sales ratio is 0.70

PS Ratio Sector Rank

19.48%
CPHI price to sales ratio is higher than 19.48% of companies in Healthcare sector

Enterprise value

Enterprise Value

$7.18 M
CPHI enterprise value is $7.18 million

Enterprise Value Sector Rank

20.84%
CPHI enterprise value is higher than 20.84% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.22
CPHI EV/EBITDA is -4.22

EV/EBITDA Sector Rank

24.49%
CPHI EV/EBITDA is higher than 24.49% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.88
CPHI annual current ratio is 0.88

Annual Quick Ratio

0.33
CPHI annual quick ratio is 0.33

Leverage

Annual Debt To Equity

0.61
CPHI annual debt to equity ratio is 0.61

Annual Interest Coverage Ratio

-8.23
CPHI annual interest coverage ratio is -8.23

Risk & Stability

Piotroski F-Score

2
CPHI piotroski f-score is 2

Altman Z-Score

-3.27
CPHI altman z-score is -3.27

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$16.47 M
CPHI annual total assets is $16.47 million

Annual Non Current Assets

$10.47 M
CPHI annual long term assets is $10.47 million

Annual Current Assets

$6.00 M
CPHI annual total current assets is $6.00 million

Annual Cash & Cash Equivalents

$1.42 M
CPHI annual cash & cash equivalents is $1.42 million

Equity

Annual Book Value

$7.45 M
CPHI annual book value is $7.45 million

Annual Working Capital

-$823.70 K
CPHI annual working capital is -$823.70 thousand

Liabilities

Annual Total Liabilities

$9.01 M
CPHI annual total liabilities is $9.01 million

Annual Total Long Term Liabilities

$2.19 M
CPHI annual total long term liabilities is $2.19 million

Annual Current Liabilities

$6.82 M
CPHI annual total current liabilities is $6.82 million

Annual Accounts Payable

$966.40 K
CPHI annual accounts payable is $966.40 thousand

Debt

Annual Total Debt

$4.63 M
CPHI annual total debt is $4.63 million

Annual Total Debt 1-Year Change

-47.08%
CPHI annual total debt is down -47.08% year-on-year

Annual Long Term Debt

$1.45 M
CPHI annual long term debt is $1.45 million

Annual Short Term Debt

$3.18 M
CPHI annual short term debt is $3.18 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$9.78 M
CPHI annual total expenses is $9.78 million

Annual Operating Expenses

$2.49 M
CPHI annual total operating expenses is $2.49 million

Annual Cost Of Goods Sold

$7.29 M
CPHI annual cost of goods sold is $7.29 million

Annual SGA

$2.25 M
CPHI annual SGA is $2.25 million

Annual D&A

$2.75 M
CPHI annual depreciation & amortization is $2.75 million

Annual Interest Expense

$333.60 K
CPHI annual interest expense is $333.60 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$699.70 K
CPHI annual cash flow from operations is -$699.70 thousand

Annual CFO 1-Year Change

-70.87%
CPHI annual cash flow from operations is down -70.87% year-on-year

Annual CFI

-$11.50 K
CPHI annual cash flow from investing activities is -$11.50 thousand

Annual CFI 1-Year Change

+97.14%
CPHI annual cash flow from investing activities is up +97.14% year-on-year

Annual CFF

$73.10 K
CPHI annual cash flow from financing activities is $73.10 thousand

Annual CFF 1-Year Change

+104.13%
CPHI annual cash flow from financing activities is up +104.13% year-on-year

Free CashFlow

Annual FCF

-$711.20 K
CPHI annual free cash flow is -$711.20 thousand

Annual FCF 1-Year Change

+12.36%
CPHI annual free cash flow is up +12.36% year-on-year

CAPEX

Annual CAPEX

$11.50 K
CPHI annual capital expenditures is $11.50 thousand

Annual CAPEX 1-Year Change

-97.14%
CPHI annual capital expenditures is down -97.14% year-on-year

Institutional Ownership

Similar stocks

ALZN logo
Alzamend Neuro (ALZN)
APVO logo
Aptevo Therapeutics (APVO)
KRBP logo
Kiromic BioPharma (KRBP)
TNON logo
Tenon Medical (TNON)
MSPR logo
MSP Recovery (MSPR)
SNPX logo
Synaptogenix (SNPX)
ELAB logo
Elevai Labs (ELAB)
CNTG logo
Centogene NV (CNTG)
TOVX logo
Theriva Biologics (TOVX)

FAQ

  • What is the ticker symbol for China Pharma Holdings?
  • Does China Pharma Holdings pay dividends?
  • What sector is China Pharma Holdings in?
  • What industry is China Pharma Holdings in?
  • What country is China Pharma Holdings based in?
  • When did China Pharma Holdings go public?
  • Is China Pharma Holdings in the S&P 500?
  • Is China Pharma Holdings in the NASDAQ 100?
  • Is China Pharma Holdings in the Dow Jones?
  • When was China Pharma Holdings's last earnings report?
  • When does China Pharma Holdings report earnings?

What is the ticker symbol for China Pharma Holdings?

The ticker symbol for China Pharma Holdings is NYSE American:CPHI

Does China Pharma Holdings pay dividends?

No, China Pharma Holdings does not pay dividends

What sector is China Pharma Holdings in?

China Pharma Holdings is in the Healthcare sector

What industry is China Pharma Holdings in?

China Pharma Holdings is in the Drug Manufacturers - Specialty & Generic industry

What country is China Pharma Holdings based in?

China Pharma Holdings is headquartered in China

When did China Pharma Holdings go public?

China Pharma Holdings's initial public offering (IPO) was on April 17, 2002

Is China Pharma Holdings in the S&P 500?

No, China Pharma Holdings is not included in the S&P 500 index

Is China Pharma Holdings in the NASDAQ 100?

No, China Pharma Holdings is not included in the NASDAQ 100 index

Is China Pharma Holdings in the Dow Jones?

No, China Pharma Holdings is not included in the Dow Jones index

When was China Pharma Holdings's last earnings report?

China Pharma Holdings's most recent earnings report was on Nov 13, 2024

When does China Pharma Holdings report earnings?

The next expected earnings date for China Pharma Holdings is May 15, 2025